Search Within

Ross Levine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition
    Journal Article

    Jeremy, W. Q.; Yang, Q.; Goldenson, B.; Malinge, S.; Lasho, T.; Schneider, R. K.; Breyfogle, L. J.; Schultz, R.; Gilles, L.; Koppikar, P.; more...
    Nature Medicine (2015)

    Fulltext@MSK | Save
  • Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias
    Journal Article

    Kucine, N.; Marubayashi, S.; Bhagwat, N.; Papalexi, E.; Koppikar, P.; Martin, M. S.; Dong, L.; Tallman, M. S.; Paietta, E.; Wang, K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Loss of BAP1 function leads to EZH2-dependent transformation
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2015)

    Fulltext@MSK | Save
  • Simulation in continuing education: Improving hematologist evidence-based decisions for myeloproliferative neoplasm management
    Meeting Abstract

    Van Laar, E.; Blevins, D.; Levine, R.; Mesa, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Ag-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant enzyme, induced durable responses in a phase 1 study of IDH2 mutation-positive advanced hematologic malignancies
    Meeting Abstract

    DiNardo, C.; Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • DNMT3A R882 mutation promote chemoresistance and therapeutic relapse through impaired DNA-damage sensing
    Meeting Abstract

    Guryanova, O.; Shank, K.; Garrett-Bakelman, F.; Spitzer, B.; Ganzel, C.; Rapaport, F.; Keller, M.; Evangelista, L.; Glass, J.; Rowe, J.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Role of JAK-STAT pathway activation in MPN pathogenesis and therapeutic response
    Meeting Abstract

    Meyer, S.; Kleppe, M.; Bhagwat, N.; Koppikar, P.; Kwak, M.; Radimerski, T.; Fan, R.; Levine, R. L.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
    Journal Article

    Walter, R. B.; Othus, M.; Paietta, E. M.; Racevskis, J.; Fernandez, H. F.; Lee, J. W.; Sun, Z.; Tallman, M. S.; Patel, J.; Gönen, M.; more...
    Leukemia (2015)

    Fulltext@MSK | Save
  • Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
    Journal Article

    Zhang, Q.; Zhao, K.; Shen, Q.; Han, Y.; Gu, Y.; Li, X.; Zhao, D.; Liu, Y.; Wang, C.; Zhang, X.; more...
    Nature (2015)

    Fulltext@MSK | Save